Literature DB >> 2667113

The relation between urinary tract infections and stone composition in renal stone formers.

K Holmgren1, B G Danielson, B Fellström, S Ljunghall, F Niklasson, B Wikström.   

Abstract

During a seven-year period (1975-1981) a total of 1325 patients hospitalized for stone disease were studied as to the occurrence of positive urine cultures. Urinary stones from 535 surgically treated patients were analyzed with infrared spectrophotometry and the relationships between stone composition, level of surgery and bacteriological strains were studied. Positive urinary cultures were found in 34% of the surgically treated patients and in 21% of those not operated upon. Among the surgically treated patients with urinary tract infection (UTI) E. coli was the most frequent microorganism (35%), followed by Proteus (28%). Patients with Proteus infection had the highest frequency of UTI episodes, most of which occurred before hospitalization. There was a higher frequency of magnesium ammonium phosphate (MAP) calculi among patients with Proteus infection than among those with non-Proteus infection, in whom no difference in stone composition was found. Patients infected with E. coli had more phosphate-containing stones (CaP+MAP) than non-infected patients. The highest frequency of oxalate calculi (CaOx+CaOx/CaP) was found among patients without infection. No E. coli infections were seen in male patients with CaP and MAP calculi. MAP stones were most often found in the kidney and oxalate stones in the ureter.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2667113     DOI: 10.3109/00365598909180827

Source DB:  PubMed          Journal:  Scand J Urol Nephrol        ISSN: 0036-5599


  11 in total

Review 1.  The association between bacteria and urinary stones.

Authors:  Andrew L Schwaderer; Alan J Wolfe
Journal:  Ann Transl Med       Date:  2017-01

2.  2018 CUA Abstracts.

Authors: 
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

3.  In vitro bactericidal effect of Ho:YAG laser and pneumatic lithotripsy on ureteral stones colonized with Escherichia coli and Enterococcus faecalis.

Authors:  Unsal Savci; Mustafa Sungur; Mustafa Sahin; Baris Eser; Selahattin Caliskan
Journal:  Urolithiasis       Date:  2019-03-20       Impact factor: 3.436

4.  Composition and morphology of phosphate stones and their relation with etiology.

Authors:  Michel Daudon; Hassan Bouzidi; Dominique Bazin
Journal:  Urol Res       Date:  2010-10-22

5.  Gas-containing renal stones: findings from five consecutive patients.

Authors:  Ted B Manny; Patrick W Mufarrij; Jessica N Lange; Majid Mirzazadeh; Ashok K Hemal; Dean G Assimos
Journal:  Urology       Date:  2012-10-24       Impact factor: 2.649

6.  Inhibitory effect of an aqueous extract of Radix Paeoniae Alba on calcium oxalate nephrolithiasis in a rat model.

Authors:  Xiaoran Li; Wenyun Wang; Yu Su; Zhongjin Yue; Junsheng Bao
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

7.  Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages.

Authors:  Parveen Kumar; Kanchan Saini; Vikram Saini; Tanecia Mitchell
Journal:  Front Immunol       Date:  2021-10-21       Impact factor: 7.561

8.  The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits.

Authors:  Evan Barr-Beare; Vijay Saxena; Evann E Hilt; Krystal Thomas-White; Megan Schober; Birong Li; Brian Becknell; David S Hains; Alan J Wolfe; Andrew L Schwaderer
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

9.  Successful ureteroscopy for kidney stone disease leads to resolution of urinary tract infections: Prospective outcomes with a 12-month follow-up.

Authors:  Rachel Oliver; Anngona Ghosh; Robert Geraghty; Sacha Moore; Bhaskar K Somani
Journal:  Cent European J Urol       Date:  2017-11-07

10.  Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years.

Authors:  Eleanor Brain; Robert M Geraghty; Paul Cook; Paul Roderick; Bhaskar Somani
Journal:  World J Urol       Date:  2021-01-05       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.